FDA Drug Approval, A075795, GLIPIZIDE
FDA Drug Approval, A075795, GLIPIZIDE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
Contents: Summary Basis for Approval
ANDA: 075795
Company: APOTEX
Drug Name: GLIPIZIDE
Active Ingredients: GLIPIZIDE
Strength: 10MG
Dosage Form/Route: TABLET;ORAL
Action Date: 06/13/2001
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AB
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details